Archives: Agenda

• Reviewing temperature control management and monitoring options to avoid excursions and waste (use of Real Time Tracking technology)
• Considering challenges and benefits of supply models such as just in time supply to increase efficiency
• Complying with regulation and quality control to limit delays

• With constantly shifting regulations, new technologies and sustainability concerns, the life science logistics sector continues to develop at a rapid pace. Biocair’s position as a leading global life sciences logistics expert at the forefront of industry excellence and customer service means the company has a unique insight into the future of this sector.
• Sustainability is now a crucial consideration within supply chain dynamics. This is part of a broader industry trend of companies collectively committing to sustainability targets.
• With a decrease in funding being observed throughout 2024, collaboration is now more than ever a top priority.
• As advances in treatments drive a shift towards personalized medicines, adherence to regulatory standards becomes paramount to ensure that sensitive and critical life science materials can be delivered to patients with the highest of care
• The impact of recent global events can still be felt throughout the world of supply chain logistics. What is clear now more than ever is the need to be agile and flexible within the rapidly moving industry, where next-generation treatments are necessitating new approaches to logistics

• Enhancing real-time data visibility and accuracy
• Streamlining compliance and regulatory adherence
• Improving flexibility and efficiency in clinical supply management

• Managing inventory, procurement and logistics for manufacturing, storage and distribution
• Optimizing drug supply based on patient needs
• Enhancing traceability, security and transparency
• Ensuring regulatory compliance and GMP/GDP processes are documented and auditable

Accelerate, cultivate, innovate!—managing relationships with the modern supplier
How Bayer’s external relationship governance model adds value to the business ensuring a reliable partnership and complements the sourcing & procurement functions within CTS scope

• Trends on procurement roles and the necessity to have an operational perspective
• Different approaches from different business necessities
• Trends on how to best manage CMOs, 3PLs and clinical trials partners

Join us as we discuss five key areas of preparation for regulatory inspections based on current industry trends:

• Audit trails
• Data Integrity – beyond ALCOA++
• Transparency and Responsibilities
• Randomization – keeping the blind in mind
• User Access Management

• Recognizing the increasing frequency of medicine shortages in Europe, and highlighting vulnerabilities in the supply chain
• Facilitating and sharing of critical medicines and resources among EU member states through the EMA MSSG Solidarity Mechanism, thereby improving supply chain resilience
• Promoting collaboration among healthcare providers